Breaking Pancreatic Cancer’s Shield | Science News

Science News Today | 2 Min News | The Daily News Now! · Sep 12, 2026 · 1m

Scientists may have uncovered a game-changing strategy to tackle pancreatic cancer’s toughest defenses: blocking the IL1RAP receptor, a key hub that fuels tumor survival and immune evasion. Early lab results show this approach dismantles protective networks, revs up T cells, and could dramatically boost the effectiveness of chemo and immunotherapy. A new clinical trial is now set to test this combo therapy in operable patients before surgery—aiming to reprogram the tumor’s environment so existing treatments can finally land a decisive blow. Listen in comfort:Get a discount on a Soli Pillow…